BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19131427)

  • 1. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
    Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
    Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma.
    Shimokawa M; Hasegawa S; Fukuoka K; Okada M; Yokoi K; Tanaka F; Yamanaka T; Daimon T; Nakano T
    Jpn J Clin Oncol; 2013 May; 43(5):575-8. PubMed ID: 23509402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
    J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
    Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
    J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
    Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W; Kirschbaum A; Passlick B
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant mesothelioma of the pleura: place of surgery].
    Giudicelli R; Regnard JF; Astoul P; Ruffie P
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980
    [No Abstract]   [Full Text] [Related]  

  • 13. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    Rusch VW; Rosenzweig K; Venkatraman E; Leon L; Raben A; Harrison L; Bains MS; Downey RJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):788-95. PubMed ID: 11581615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK; Ye Z; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Monberg MJ; Jänne PA;
    Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
    Pasello G; Marulli G; Polo V; Breda C; Bonanno L; Loreggian L; Rea F; Favaretto A
    Anticancer Res; 2012 Dec; 32(12):5393-9. PubMed ID: 23225442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.
    Federico R; Adolfo F; Giuseppe M; Lorenzo S; Martino DT; Anna C; Adriano P; Gino C; Francesca R; Matteo C; Gbenga K; Paolo M; Francesco F
    BMC Cancer; 2013 Jan; 13():22. PubMed ID: 23324131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
    Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
    Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.